The Stanford Stroke Center, one of the first comprehensive multidisciplinary centers of its kind, was established in 1992 to develop new approaches to diagnose and treat stroke. The mission of the Stroke Center is to be the best comprehensive organization in the United States focused on stroke diagnosis, treatment, research, and education. In 1992 the Center was established by a team of neurologists, neurosurgeons, neuroradiologists, nurse specialists, basic scientists, and clinical researchers. This multi- disciplinary team has met regularly to continually refine the program for over 20 years. In 2012, the Joint Commission and the American Heart Association/American Stroke Association announced that the Stanford Stroke Center was the first hospital in the United States to meet The Joint Commission's standards for Disease-Specific Care Comprehensive Stroke Center Certification. In conjunction with Stanford's highly successful neurological emergency treatment trials network (NETT), the Stanford-RCC will provide high volume enrollment of diverse patient populations into NINDS funded stroke trials. The Stanford-RCC will also offer an innovative multidisciplinary fellowship program that will provide comprehensive training in clinical trial design, implementation and analysis. In addition, Stanford faculty members will propose new clinical trials for implementation through the new NINDS Stroke Network.
The Stanford Stroke Center will develop a comprehensive stroke network consisting of 10 clinical trial sites that will provide a high volume of patient enrollment into NINDS funded stroke trials. The network will create a fellowship program that will provide comprehensive training in clinical trial design, implementation and analysis. In addition, Stanford faculty members will propose new clinical trials for implementation through the new NINDS Stroke Network.
|Albers, Gregory W (2018) Late Window Paradox. Stroke 49:768-771|
|Albers, Gregory W; Marks, Michael P; Kemp, Stephanie et al. (2018) Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med 378:708-718|
|Marks, Michael P; Heit, Jeremy J; Lansberg, Maarten G et al. (2018) Endovascular Treatment in the DEFUSE 3 Study. Stroke 49:2000-2003|
|Albers, Gregory W; Lansberg, Maarten G; Kemp, Stephanie et al. (2017) A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke 12:896-905|
|Kasasbeh, Aimen S; Christensen, Søren; Straka, Matus et al. (2016) Optimal Computed Tomographic Perfusion Scan Duration for Assessment of Acute Stroke Lesion Volumes. Stroke 47:2966-2971|
|Lansberg, Maarten G; Bhat, Ninad S; Yeatts, Sharon D et al. (2016) Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data. Stroke 47:2931-2937|
|Liebeskind, David S; Albers, Gregory W; Crawford, Karen et al. (2015) Imaging in StrokeNet: Realizing the Potential of Big Data. Stroke 46:2000-6|